Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹260.23
5.14 (2.01%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.40K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹162.19+60.4%
52W High₹349.8-25.6%
Current Price
₹260.23
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹208.18
Upper Circuit₹312.28
Reference Price
₹260.23
Investment Checklist
Rounding Bottom on 1W (BREAKOUT CONFIRMED) — target ₹260.77
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
3-day momentum: +8.2% — strong upward pressure
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
50%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
238.75
EMA50
227.04
EMA200
239.2
Price Action
UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2
Support & Resistance Levels
Resistance (Above)
₹260.86
₹270.00
₹281.58
₹288.00
₹291.00
Support (Below)
₹257.35
₹254.00
₹250.10
₹235.80
₹227.85
Volume Analysis
TrendDECREASING
Change-55.20%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹257.63
3% Risk₹252.42
5% Risk₹247.22
7% Risk (Custom)
₹242.01Technical Levels
1x ATR (Volatility)₹247.99
2x ATR (Swing)₹235.75
3x ATR (Trend)₹223.51
Immediate Support₹257.35
Moving Averages
EMA 9 (Short-term)₹246.58
EMA 20 (Medium-term)₹238.75
EMA 50 (Trend)₹227.04
EMA 200 (Long-term)₹239.20
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹383.9 Cr | ₹429.1 Cr | ₹471.8 Cr | ₹434.3 Cr |
| Net Profit | ₹-40.4 Cr | ₹-35.8 Cr | ₹-7.9 Cr | ₹-29.8 Cr |
| EPS | — | ₹-3.94 | ₹-1.00 | ₹-3.20 |
| Operating Profit | ₹-3 Cr | ₹19.2 Cr | ₹43.3 Cr | ₹26.3 Cr |
ROE
-7.21%
ROCE
-0.61%
Debt/Equity
0.97
Current Ratio
1.24
OPM
6.06%
NPM
-6.86%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Indoco Remedies Limited | ₹260.23 | +2.01% | — | ₹2.40K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 04 Sept 2025 | Dividend - Re 0.20 Per Share | DIVIDEND |
| 19 Sept 2024 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
| 18 Sept 2023 | Annual General Meeting/Dividend - Rs 2.25 Per Share | AGM |
| 14 Sept 2022 | Annual General Meeting/Dividend - Rs 1.50 Per Share/Special Dividend- Rs 0.75 Per Share | AGM |
| 17 Sept 2021 | Annual General Meeting/Dividend - Rs 1.50 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for INDOCO
View All
positive
CNBC TV18 - Markets 14d ago
Indoco Remedies' Goa plant secures EU GMP certification from Malta regulator
Indoco Remedies has received EU GMP certification for its Goa manufacturing facility from the Malta Medicines Authority, bolstering its regulatory credentials in Europe and extending a series of recent compliance approvals across key production sites.
INDOCOHealthcare
NEWS
neutral
Business Standard - Markets 15d ago
Indoco Remedies receives EU GMP certification for its Goa unit
From Malta Medicines Authority
INDOCOHealthcare
NEWS
neutral
Business Standard - Markets 30d ago
PPAP Automotive Ltd leads gainers in 'B' group
Unichem Laboratories Ltd, Indoco Remedies Ltd, AVG Logistics Ltd and Motisons Jewellers Ltd are among the other gainers in the BSE's 'B' group today, 11 June 2026.
AVGAVG-REBSEINDOCOMOTISONSPPAPSJLOGISTICUNICHEMLABAutomobile and Auto ComponentsConsumer Durables